Glucocorticoid receptor blockade as disease-modifying treatment for depression with childhood trauma: a study protocol of the RESET-medication study

被引：0
|
作者：
Linsen, F. [1 ]
Verhoeven, J. [1 ]
Bet, P. [1 ]
Penninx, B. [1 ]
Meijer, O. [2 ]
Vinkers, C. [1 ]
机构：
[1] Amsterdam UMC Locat VUmc, Dept Psychiat, Amsterdam, Netherlands
[2] Leiden UMC, Dept Med, Div Endocrinol, Leiden, Netherlands
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2021年 / 53卷
关键词：
D O I：
10.1016/j.euroneuro.2021.10.772
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.0700
引用
收藏
页码：S513 / S513
页数：1
相关论文
共 50 条
  • [1] Glucocorticoid Receptor (GR) antagonism as disease-modifying treatment for MDD with childhood trauma: protocol of the RESET-medication randomized controlled trial
    Linsen, F.
    Broeder, C.
    Sep, M. S. C.
    Verhoeven, J. E.
    Bet, P. M.
    Penninx, B. W. J. H.
    Meijer, O. C.
    Vinkers, C. H.
    BMC PSYCHIATRY, 2023, 23 (01)
  • [2] Glucocorticoid Receptor (GR) antagonism as disease-modifying treatment for MDD with childhood trauma: protocol of the RESET-medication randomized controlled trial
    F. Linsen
    C. Broeder
    M. S. C. Sep
    J. E. Verhoeven
    P. M. Bet
    B. W. J. H. Penninx
    O. C. Meijer
    C. H. Vinkers
    BMC Psychiatry, 23
  • [3] Disease-modifying therapy improved depression symptoms in multiple sclerosis patients: the POSIDONIA study
    Montanari, E.
    Conti, M.
    Maimone, D.
    Clerici, V. Torri
    Plewnia, K.
    Frigo, M.
    Francia, A.
    Pala, A.
    Veneziano, A.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 321 - 321
  • [4] Termination of disease-modifying drugs in psoriatic arthritis: Study of 109 courses of treatment
    GomezVaquero, C
    RodriguezMoreno, J
    Ros, S
    Marcos, R
    Fiter, J
    RoigEscofet, D
    BRITISH JOURNAL OF RHEUMATOLOGY, 1996, 35 (06): : 564 - 567
  • [5] Impact of Childhood Trauma on Treatment Outcome in the Treatment for Adolescents with Depression Study (TADS)
    Lewis, Cara C.
    Simons, Anne D.
    Nguyen, Lananh J.
    Murakami, Jessica L.
    Reid, Mark W.
    Silva, Susan G.
    March, John S.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2010, 49 (02): : 132 - 140
  • [6] Ambroxol as a Disease-Modifying Treatment to Reduce the Risk of Cognitive Impairment in GBA-Associated Parkinson's Disease: The AMBITIOUS Study Protocol
    Colucci, F.
    Avenali, M.
    De Micco, R.
    Bacila, A.
    Cerri, S.
    Cuconato, G.
    Franco, V.
    Franciotta, D.
    Ghezzi, C.
    Gastaldi, M.
    Galandra, C.
    Germani, G.
    Mitrotti, P.
    Ongari, G.
    Palmieri, I.
    Picascia, M.
    Pichiecchio, A.
    Esposito, F.
    Cirillo, M.
    Di Nardo, F.
    Aloisio, S.
    Siciliano, M.
    Poli, M. Fusar
    Stanziano, M.
    Garavaglia, B.
    Cazzaniga, F.
    Reale, C.
    Tramacere, I.
    Priori, S.
    Amami, P.
    Piacentini, S.
    Bruzzone, M. G.
    Grisoli, M.
    Moda, F.
    Eleopra, R.
    Tessitore, A.
    Valente, E. M.
    Cilia, R.
    MOVEMENT DISORDERS, 2023, 38 : S19 - S20
  • [7] MEDICATION ADHERENCE IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: A REGISTER STUDY
    Joensuu, J. T.
    Aaltonen, K. J.
    Valleala, H.
    Puolakka, K.
    Yli-Kerttula, T.
    Varjolahti-Lehtinen, T.
    Sokka, T.
    Blom, M.
    Nordstrom, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 882 - 883
  • [8] Brain tDCS as a disease-modifying treatment of MS: A pilot study in a chronic EAE model
    Santangelo, R.
    Castoldi, V.
    Finardi, A.
    Cursi, M.
    Camaleonti, L.
    Comi, G.
    Furlan, R.
    Leocani, L.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 569 - 570
  • [9] Glucocorticoid resistance, childhood trauma and antidepressant response in patients with depression: Results from BIODEP study UK
    Nikkheslat, N.
    McLaughlin, A. P.
    Hastings, C.
    Zajkowska, Z.
    Nettis, M. A.
    Mariani, N.
    Enache, D.
    Lombardo, G.
    Pointon, L.
    Cowen, P. J.
    Cavanagh, J.
    Harrison, N. A.
    Bullmore, E. T.
    Consortium, N.
    Pariante, C. M.
    Mondelli, V.
    BRAIN BEHAVIOR AND IMMUNITY, 2019, 81 : 16 - 16
  • [10] Expected wait times for access to a disease-modifying Alzheimer's treatment in England: A modelling study
    Mattke, Soeren
    Tang, Yu
    Hanson, Mark
    JOURNAL OF HEALTH SERVICES RESEARCH & POLICY, 2024, 29 (02) : 69 - 75
12345